Brain Biomarkers Market
Market Insights on Brain Biomarkers covering sales outlook, demand forecast & up-to-date key trends
Brain Biomarkers Market By Product Type, Disease Indication, Application, End use & Region - Forecast 2022 – 2032
Brain Biomarkers Market Snapshot (2022-2032)
[250 Pages Report] The global brain biomarkers market is anticipated to exhibit growth at a CAGR of 14.3% in the forecast period from 2022 to 2032. It is set to reach US$ 8.3 Billion in 2022 and US$ 11.5 Billion in 2032. The rising prevalence of various neurological diseases, such as brain tumors, migraines, epilepsy, and dementia is projected to drive the sales of brain biomarkers in future years.
|
Report Attribute |
Details |
|
Brain Biomarkers Market Estimated Base Year Value (2021) |
US$ 7.1 Billion |
|
Brain Biomarkers Market Expected Market Value (2022) |
US$ 8.3 Billion |
|
Brain Biomarkers Market Anticipated Forecast Value (2032) |
US$ 11.5 Billion |
|
Brain Biomarkers Market Projected Growth Rate (2022-2032) |
14.3% CAGR |
Biomarkers are referred to as molecules that indicate the presence of a dysfunction or disease. These are becoming increasingly important for monitoring disease progression, selecting the best treatments, and confirming diagnoses.
Neurological biomarkers are mainly present in Cerebrospinal Fluid (CSF) and rarely in blood. These can be studied by using CSF, but require an invasive lumbar puncture procedure.
Biomarker signatures are considered to be another powerful tool for studying neurological conditions and diseases. These are detected with the help of panels of high-quality antibodies.
The development of genomic biomarkers is projected to create new opportunities for the introduction of diagnostics that are based on a person’s specific genetic variations. Genomic biomarkers are also expected to help in the creation of personalized medicines.
Let us know your requirement to get
100% FREE customization
Which are Some Major Factors Spurring Growth of the Brain Biomarkers Market
The ongoing technological advancement in the field of biomarkers and the emergence of biomarker signatures are expected to make neurological diseases more treatable. This is further expected to result in the early diagnosis, faster drug development, and non-invasive testing.
The launch of digital biomarkers by key players is set to deliver numerous pharmaceutical companies supplemental and contextual information to conclude clinical trials efficiently. Besides, government funding to accelerate research and development activities in various countries is expected to propel the demand for brain biomarkers in the assessment period.
Which Factors May Restrain the Brain Biomarkers Market Growth
The usage of brain biomarkers is limited to researchers for better understanding the disease progression. Several pharmaceutical and pathology companies worldwide are also using these to rapidly develop new therapeutics for neurodegenerative disorders. The lack of availability of commercial or direct-to-consumer tests may hamper the brain biomarkers market size in the near future.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhy is North America Projected to Dominate the Brain Biomarkers Market
North America is anticipated to lead in terms of the brain biomarkers market share during the forthcoming years. This growth is attributable to the rising research funding by regulatory bodies and the surging acceptance of biomarkers for drug development purposes in the U.S. and Canada.
The increasing prevalence of various neurological diseases across these developed countries is another significant factor that is estimated to augur well for the market.
As per the Centers for Disease Control and Prevention (CDC), at present, nearly 5.8 million people have Alzheimer’s disease in the U.S. Cases of Alzheimer’s disease are expected to reach 14 million by 2060 in the country. These numbers are projected to grow at a fast pace, thereby propelling the North America market.
How is the Asia Pacific Brain Biomarkers Market Progressing
Asia Pacific is likely to exhibit a CAGR of 15.4% in the forecast period from 2022 to 2032. The rising number of clinical trials that are being conducted in China, Japan, India, and South Korea is projected to drive the Asia Pacific brain biomarkers market growth in future years.
The surging demand for targeted drugs to treat conditions associated with the central nervous system is another vital factor that is anticipated to augment the growth in the regional market. According to the National Health Portal, in India, the prevalence of dementia is set to be around 2.7%. This condition poses a great challenge in the country owing to the surging geriatric population. This factor is also expected to fuel the regional market.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Market Competition
Majority of the key players operating in the global market are striving to incorporate the latest technologies to make it easier for researchers to track the condition of the brain by measuring its molecules. They are consistently developing innovative brain testing methods to provide new treatment options and enable faster diagnosis. Meanwhile, a few other key players are aiming to invest huge sums in clinical trials to boost new product development.
Some of the leading companies present in the global brain biomarkers market include Siemens Healthineers, Electrical Geodesics, Lifesign LLC, Advanced Brain Monitoring, BrainScope, GE Healthcare, Johnson & Johnson, Natus Medical, F. Hoffmann-La Roche Ltd., Qiagen N.V., Nexus-DX, and NeuroVista among others.
Report Scope
|
Report Attribute |
Details |
|
Growth Rate |
CAGR of 14.3% from 2022 to 2032 |
|
Base Year for Estimation |
2021 |
|
Historical Data |
2015-2020 |
|
Forecast Period |
2022-2032 |
|
Quantitative Units |
Revenue in USD Million and CAGR from 2022-2032 |
|
Report Coverage |
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
|
Segments Covered |
|
|
Regions Covered |
|
|
Key Countries Profiled |
|
|
Key Companies Profiled |
|
|
Customization |
Available Upon Request |
Key Segments Profiled in the Brain Biomarkers Industry Survey
By Product Type:
- Biomarker Test Kits
- Biomarker Analyzers
By Disease Indication:
- Stroke
- MND & ALS
- Alzheimer’s Disease & Other Dementias
- Parkinson’s Disease
- Huntington’s Disease
By Application:
- Diagnosis
- Drug Discovery and Development
- Others
By End User:
- Hospitals
- Research Laboratories
- Ambulatory Surgical Centers
- Diagnostic Laboratories
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- APEJ
- Japan
- Middle East and Africa
Frequently Asked Questions
The global brain biomarkers market is anticipated to surpass US$ 11.5 Billion in 2032.
North America is set to lead the brain biomarkers market in the forecast period.
Siemens Healthineers, Electrical Geodesics, Lifesign LLC, Advanced Brain Monitoring, BrainScope, GE Healthcare, and Johnson & Johnson are some of the renowned companies in the brain biomarkers market.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. Value Chain Analysis
3.5.1. Profit Margin Analysis
3.5.2. Service Providers
3.6. PESTLE and Porter’s Analysis
3.7. Regulatory Landscape
3.7.1. By Key Regions
3.7.2. By Key Countries
3.8. Regional Parent Market Outlook
4. Global Brain Biomarkers Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Biomarkers
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Biomarkers, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Biomarkers, 2022-2032
5.3.1. Genomics Biomarkers
5.3.2. Proteomic Biomarkers
5.3.3. Metabolomics Biomarkers
5.3.4. Imaging Biomarkers
5.3.5. Other Biomarkers
5.4. Y-o-Y Growth Trend Analysis By Biomarkers, 2017-2021
5.5. Absolute $ Opportunity Analysis By Biomarkers, 2022-2032
Deep-dive segmentation will be available in the sample on request
6. Global Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Indication
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Indication, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Indication, 2022-2032
6.3.1. Alzheimer’s Disease
6.3.2. Parkinson’s Disease
6.3.3. Huntington’s Disease
6.3.4. Schizophrenia
6.3.5. Depression
6.3.6. Multiple Sclerosis
6.3.7. Spinal Muscular Atrophy
6.4. Y-o-Y Growth Trend Analysis By Indication, 2017-2021
6.5. Absolute $ Opportunity Analysis By Indication, 2022-2032
Deep-dive segmentation will be available in the sample on request
7. Global Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By End Users
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By End Users, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End Users, 2022-2032
7.3.1. Academic & Research Institutes
7.3.2. Diagnostic Laboratories
7.3.3. Hospitals
7.4. Y-o-Y Growth Trend Analysis By End Users, 2017-2021
7.5. Absolute $ Opportunity Analysis By End Users, 2022-2032
Deep-dive segmentation will be available in the sample on request
8. Global Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. East Asia
8.3.5. South Asia & Pacific
8.3.6. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Biomarkers
9.2.3. By Indication
9.2.4. By End Users
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Biomarkers
9.3.3. By Indication
9.3.4. By End Users
9.4. Key Takeaways
10. Latin America Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Mexico
10.2.1.2. Brazil
10.2.1.3. Rest of Latin America
10.2.2. By Biomarkers
10.2.3. By Indication
10.2.4. By End Users
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Biomarkers
10.3.3. By Indication
10.3.4. By End Users
10.4. Key Takeaways
11. Europe Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. Italy
11.2.1.3. France
11.2.1.4. U.K.
11.2.1.5. Spain
11.2.1.6. BENELUX
11.2.1.7. Russia
11.2.1.8. Rest of Europe
11.2.2. By Biomarkers
11.2.3. By Indication
11.2.4. By End Users
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Biomarkers
11.3.3. By Indication
11.3.4. By End Users
11.4. Key Takeaways
12. East Asia Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Biomarkers
12.2.3. By Indication
12.2.4. By End Users
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Biomarkers
12.3.3. By Indication
12.3.4. By End Users
12.4. Key Takeaways
13. South Asia & Pacific Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. India
13.2.1.2. ASEAN
13.2.1.3. Australia and New Zealand
13.2.1.4. Rest of South Asia & Pacific
13.2.2. By Biomarkers
13.2.3. By Indication
13.2.4. By End Users
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Biomarkers
13.3.3. By Indication
13.3.4. By End Users
13.4. Key Takeaways
14. MEA Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. Turkey
14.2.1.3. South Africa
14.2.1.4. Rest of MEA
14.2.2. By Biomarkers
14.2.3. By Indication
14.2.4. By End Users
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Biomarkers
14.3.3. By Indication
14.3.4. By End Users
14.4. Key Takeaways
15. Key Countries Brain Biomarkers Market Analysis
15.1. U.S.
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2021
15.1.2.1. By Biomarkers
15.1.2.2. By Indication
15.1.2.3. By End Users
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2021
15.2.2.1. By Biomarkers
15.2.2.2. By Indication
15.2.2.3. By End Users
15.3. Mexico
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2021
15.3.2.1. By Biomarkers
15.3.2.2. By Indication
15.3.2.3. By End Users
15.4. Brazil
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2021
15.4.2.1. By Biomarkers
15.4.2.2. By Indication
15.4.2.3. By End Users
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2021
15.5.2.1. By Biomarkers
15.5.2.2. By Indication
15.5.2.3. By End Users
15.6. Italy
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2021
15.6.2.1. By Biomarkers
15.6.2.2. By Indication
15.6.2.3. By End Users
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2021
15.7.2.1. By Biomarkers
15.7.2.2. By Indication
15.7.2.3. By End Users
15.8. U.K.
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2021
15.8.2.1. By Biomarkers
15.8.2.2. By Indication
15.8.2.3. By End Users
15.9. Spain
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2021
15.9.2.1. By Biomarkers
15.9.2.2. By Indication
15.9.2.3. By End Users
15.10. BENELUX
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2021
15.10.2.1. By Biomarkers
15.10.2.2. By Indication
15.10.2.3. By End Users
15.11. Russia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2021
15.11.2.1. By Biomarkers
15.11.2.2. By Indication
15.11.2.3. By End Users
15.12. China
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2021
15.12.2.1. By Biomarkers
15.12.2.2. By Indication
15.12.2.3. By End Users
15.13. Japan
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2021
15.13.2.1. By Biomarkers
15.13.2.2. By Indication
15.13.2.3. By End Users
15.14. South Korea
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2021
15.14.2.1. By Biomarkers
15.14.2.2. By Indication
15.14.2.3. By End Users
15.15. India
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2021
15.15.2.1. By Biomarkers
15.15.2.2. By Indication
15.15.2.3. By End Users
15.16. ASEAN
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2021
15.16.2.1. By Biomarkers
15.16.2.2. By Indication
15.16.2.3. By End Users
15.17. Australia and New Zealand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2021
15.17.2.1. By Biomarkers
15.17.2.2. By Indication
15.17.2.3. By End Users
15.18. GCC Countries
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2021
15.18.2.1. By Biomarkers
15.18.2.2. By Indication
15.18.2.3. By End Users
15.19. Turkey
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2021
15.19.2.1. By Biomarkers
15.19.2.2. By Indication
15.19.2.3. By End Users
15.20. South Africa
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2021
15.20.2.1. By Biomarkers
15.20.2.2. By Indication
15.20.2.3. By End Users
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Biomarkers
16.3.3. By Indication
16.3.4. By End Users
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Merck KGaA
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. Quanterix
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. Myriad RBM
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. QIAGEN
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. ADx NeuroSciences NV
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. Thermo Fisher Scientific
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. BioAgilytix
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. ACOBIOM
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. Banyan Biomarkers, Inc.
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. Olink Biosciences
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
17.1.11. Illumina, Inc.
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.11.5.2. Product Strategy
17.1.11.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Brain Biomarkers Market Value (US$ Mn) Forecast by Region, 2017-2032
Table 2: Global Brain Biomarkers Market Value (US$ Mn) Forecast by Biomarkers, 2017-2032
Table 3: Global Brain Biomarkers Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 4: Global Brain Biomarkers Market Value (US$ Mn) Forecast by End Users, 2017-2032
Table 5: North America Brain Biomarkers Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 6: North America Brain Biomarkers Market Value (US$ Mn) Forecast by Biomarkers, 2017-2032
Table 7: North America Brain Biomarkers Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 8: North America Brain Biomarkers Market Value (US$ Mn) Forecast by End Users, 2017-2032
Table 9: Latin America Brain Biomarkers Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 10: Latin America Brain Biomarkers Market Value (US$ Mn) Forecast by Biomarkers, 2017-2032
Table 11: Latin America Brain Biomarkers Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 12: Latin America Brain Biomarkers Market Value (US$ Mn) Forecast by End Users, 2017-2032
Table 13: Europe Brain Biomarkers Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 14: Europe Brain Biomarkers Market Value (US$ Mn) Forecast by Biomarkers, 2017-2032
Table 15: Europe Brain Biomarkers Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 16: Europe Brain Biomarkers Market Value (US$ Mn) Forecast by End Users, 2017-2032
Table 17: East Asia Brain Biomarkers Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 18: East Asia Brain Biomarkers Market Value (US$ Mn) Forecast by Biomarkers, 2017-2032
Table 19: East Asia Brain Biomarkers Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 20: East Asia Brain Biomarkers Market Value (US$ Mn) Forecast by End Users, 2017-2032
Table 21: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 22: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Forecast by Biomarkers, 2017-2032
Table 23: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 24: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Forecast by End Users, 2017-2032
Table 25: MEA Brain Biomarkers Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 26: MEA Brain Biomarkers Market Value (US$ Mn) Forecast by Biomarkers, 2017-2032
Table 27: MEA Brain Biomarkers Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 28: MEA Brain Biomarkers Market Value (US$ Mn) Forecast by End Users, 2017-2032
Table 29: MEA Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032
Table 30: MEA Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032
Table 31: MEA Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Table 32: MEA Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Table 33: MEA Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032
Table 34: MEA Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032
Table 35: MEA Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032
Table 36: MEA Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032
Table 37: MEA Brain Biomarkers Market Attractiveness by Indication, 2022-2032
Table 38: MEA Brain Biomarkers Market Attractiveness by End Users, 2022-2032
Table 39: MEA Brain Biomarkers Market Attractiveness by Country, 2022-2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Brain Biomarkers Market Value (US$ Mn) by Biomarkers, 2022-2032
Figure 2: Global Brain Biomarkers Market Value (US$ Mn) by Indication, 2022-2032
Figure 3: Global Brain Biomarkers Market Value (US$ Mn) by End Users, 2022-2032
Figure 4: Global Brain Biomarkers Market Value (US$ Mn) by Region, 2022-2032
Figure 5: Global Brain Biomarkers Market Value (US$ Mn) Analysis by Region, 2017-2032
Figure 6: Global Brain Biomarkers Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 7: Global Brain Biomarkers Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 8: Global Brain Biomarkers Market Value (US$ Mn) Analysis by Biomarkers, 2017-2032
Figure 9: Global Brain Biomarkers Market Value Share (%) and BPS Analysis by Biomarkers, 2022-2032
Figure 10: Global Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032
Figure 11: Global Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 12: Global Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 13: Global Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 14: Global Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032
Figure 15: Global Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032
Figure 16: Global Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032
Figure 17: Global Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032
Figure 18: Global Brain Biomarkers Market Attractiveness by Indication, 2022-2032
Figure 19: Global Brain Biomarkers Market Attractiveness by End Users, 2022-2032
Figure 20: Global Brain Biomarkers Market Attractiveness by Region, 2022-2032
Figure 21: North America Brain Biomarkers Market Value (US$ Mn) by Biomarkers, 2022-2032
Figure 22: North America Brain Biomarkers Market Value (US$ Mn) by Indication, 2022-2032
Figure 23: North America Brain Biomarkers Market Value (US$ Mn) by End Users, 2022-2032
Figure 24: North America Brain Biomarkers Market Value (US$ Mn) by Country, 2022-2032
Figure 25: North America Brain Biomarkers Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 26: North America Brain Biomarkers Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 27: North America Brain Biomarkers Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 28: North America Brain Biomarkers Market Value (US$ Mn) Analysis by Biomarkers, 2017-2032
Figure 29: North America Brain Biomarkers Market Value Share (%) and BPS Analysis by Biomarkers, 2022-2032
Figure 30: North America Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032
Figure 31: North America Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 32: North America Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 33: North America Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 34: North America Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032
Figure 35: North America Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032
Figure 36: North America Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032
Figure 37: North America Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032
Figure 38: North America Brain Biomarkers Market Attractiveness by Indication, 2022-2032
Figure 39: North America Brain Biomarkers Market Attractiveness by End Users, 2022-2032
Figure 40: North America Brain Biomarkers Market Attractiveness by Country, 2022-2032
Figure 41: Latin America Brain Biomarkers Market Value (US$ Mn) by Biomarkers, 2022-2032
Figure 42: Latin America Brain Biomarkers Market Value (US$ Mn) by Indication, 2022-2032
Figure 43: Latin America Brain Biomarkers Market Value (US$ Mn) by End Users, 2022-2032
Figure 44: Latin America Brain Biomarkers Market Value (US$ Mn) by Country, 2022-2032
Figure 45: Latin America Brain Biomarkers Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 46: Latin America Brain Biomarkers Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 47: Latin America Brain Biomarkers Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 48: Latin America Brain Biomarkers Market Value (US$ Mn) Analysis by Biomarkers, 2017-2032
Figure 49: Latin America Brain Biomarkers Market Value Share (%) and BPS Analysis by Biomarkers, 2022-2032
Figure 50: Latin America Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032
Figure 51: Latin America Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 52: Latin America Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 53: Latin America Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 54: Latin America Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032
Figure 55: Latin America Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032
Figure 56: Latin America Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032
Figure 57: Latin America Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032
Figure 58: Latin America Brain Biomarkers Market Attractiveness by Indication, 2022-2032
Figure 59: Latin America Brain Biomarkers Market Attractiveness by End Users, 2022-2032
Figure 60: Latin America Brain Biomarkers Market Attractiveness by Country, 2022-2032
Figure 61: Europe Brain Biomarkers Market Value (US$ Mn) by Biomarkers, 2022-2032
Figure 62: Europe Brain Biomarkers Market Value (US$ Mn) by Indication, 2022-2032
Figure 63: Europe Brain Biomarkers Market Value (US$ Mn) by End Users, 2022-2032
Figure 64: Europe Brain Biomarkers Market Value (US$ Mn) by Country, 2022-2032
Figure 65: Europe Brain Biomarkers Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 66: Europe Brain Biomarkers Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 67: Europe Brain Biomarkers Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 68: Europe Brain Biomarkers Market Value (US$ Mn) Analysis by Biomarkers, 2017-2032
Figure 69: Europe Brain Biomarkers Market Value Share (%) and BPS Analysis by Biomarkers, 2022-2032
Figure 70: Europe Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032
Figure 71: Europe Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 72: Europe Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 73: Europe Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 74: Europe Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032
Figure 75: Europe Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032
Figure 76: Europe Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032
Figure 77: Europe Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032
Figure 78: Europe Brain Biomarkers Market Attractiveness by Indication, 2022-2032
Figure 79: Europe Brain Biomarkers Market Attractiveness by End Users, 2022-2032
Figure 80: Europe Brain Biomarkers Market Attractiveness by Country, 2022-2032
Figure 81: East Asia Brain Biomarkers Market Value (US$ Mn) by Biomarkers, 2022-2032
Figure 82: East Asia Brain Biomarkers Market Value (US$ Mn) by Indication, 2022-2032
Figure 83: East Asia Brain Biomarkers Market Value (US$ Mn) by End Users, 2022-2032
Figure 84: East Asia Brain Biomarkers Market Value (US$ Mn) by Country, 2022-2032
Figure 85: East Asia Brain Biomarkers Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 86: East Asia Brain Biomarkers Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 87: East Asia Brain Biomarkers Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 88: East Asia Brain Biomarkers Market Value (US$ Mn) Analysis by Biomarkers, 2017-2032
Figure 89: East Asia Brain Biomarkers Market Value Share (%) and BPS Analysis by Biomarkers, 2022-2032
Figure 90: East Asia Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032
Figure 91: East Asia Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 92: East Asia Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 93: East Asia Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 94: East Asia Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032
Figure 95: East Asia Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032
Figure 96: East Asia Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032
Figure 97: East Asia Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032
Figure 98: East Asia Brain Biomarkers Market Attractiveness by Indication, 2022-2032
Figure 99: East Asia Brain Biomarkers Market Attractiveness by End Users, 2022-2032
Figure 100: East Asia Brain Biomarkers Market Attractiveness by Country, 2022-2032
Figure 101: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) by Biomarkers, 2022-2032
Figure 102: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) by Indication, 2022-2032
Figure 103: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) by End Users, 2022-2032
Figure 104: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) by Country, 2022-2032
Figure 105: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 106: South Asia & Pacific Brain Biomarkers Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 107: South Asia & Pacific Brain Biomarkers Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 108: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Analysis by Biomarkers, 2017-2032
Figure 109: South Asia & Pacific Brain Biomarkers Market Value Share (%) and BPS Analysis by Biomarkers, 2022-2032
Figure 110: South Asia & Pacific Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032
Figure 111: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 112: South Asia & Pacific Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 113: South Asia & Pacific Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 114: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032
Figure 115: South Asia & Pacific Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032
Figure 116: South Asia & Pacific Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032
Figure 117: South Asia & Pacific Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032
Figure 118: South Asia & Pacific Brain Biomarkers Market Attractiveness by Indication, 2022-2032
Figure 119: South Asia & Pacific Brain Biomarkers Market Attractiveness by End Users, 2022-2032
Figure 120: South Asia & Pacific Brain Biomarkers Market Attractiveness by Country, 2022-2032
Figure 121: MEA Brain Biomarkers Market Value (US$ Mn) by Biomarkers, 2022-2032
Figure 122: MEA Brain Biomarkers Market Value (US$ Mn) by Indication, 2022-2032
Figure 123: MEA Brain Biomarkers Market Value (US$ Mn) by End Users, 2022-2032
Figure 124: MEA Brain Biomarkers Market Value (US$ Mn) by Country, 2022-2032
Figure 125: MEA Brain Biomarkers Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 126: MEA Brain Biomarkers Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 127: MEA Brain Biomarkers Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 128: MEA Brain Biomarkers Market Value (US$ Mn) Analysis by Biomarkers, 2017-2032
Figure 129: MEA Brain Biomarkers Market Value Share (%) and BPS Analysis by Biomarkers, 2022-2032
Figure 130: MEA Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032
Figure 131: MEA Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 132: MEA Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 133: MEA Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 134: MEA Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032
Figure 135: MEA Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032
Figure 136: MEA Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032
Figure 137: MEA Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032
Figure 138: MEA Brain Biomarkers Market Attractiveness by Indication, 2022-2032
Figure 139: MEA Brain Biomarkers Market Attractiveness by End Users, 2022-2032
Figure 140: MEA Brain Biomarkers Market Attractiveness by Country, 2022-2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
